Showing results (91-100 of 183) with videos related to
Sort By:
Pageof 19
Cancer Detection and Prevention|September 12, 2006
Nipple aspirate fluid color is associated with breast cancerEdward R Sauter, Justin N Winn, Paul S Dale, et al.BMC Medical Research Methodology|September 20, 2002
Statistical issues in randomized trials of cancer screeningStuart G Baker, Barnett S Kramer, Philip C ProrokDisease Markers|August 24, 2004
Development tracks for cancer prevention markersStuart G Baker, Barnett S Kramer, Philip C ProrokCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancerEdward R Sauter, Lisa Schlatter, John Hewett, et al.Biostatistics (Oxford, England)|August 20, 2003
A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability surveyStuart G Baker, Chia-Wen Ko, Barry I GraubardBMC Medical Research Methodology|May 20, 2004
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability designStuart G Baker, Barrett S Kramer, Philip C ProrokBiometrics|March 2, 2005
Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twinsStuart G Baker, Paul Lichtenstein, Jaakko Kaprio, et al.Trials|October 7, 2006
Selecting patients for randomized trials: a systematic approach based on risk groupAndrew J Vickers, Barry S Kramer, Stuart G BakerJournal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C ProrokThe International Journal of Biostatistics|June 21, 2011
Clarifying the role of principal stratification in the paired availability designStuart G Baker, Karen S Lindeman, Barnett S KramerPageof 19